Finance

Beta
Lists
300966:SHE
Hubei Goto Biopharm Group Co Ltd
CN¥26.06
-10.39%
(-3.02) 1D
Jul 17, 3:04:49 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300966...
Open
CN¥28.50
High
CN¥28.78
Low
CN¥25.50
Mkt. cap
3.35B
Avg. vol.
5.78M
Volume
7.05M
Dividend
0.17%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jul 16, 2026
52-wk high
CN¥32.58
52-wk low
CN¥18.44
EPS
-CN¥0.63
Shares outstanding
115.28M
No. of employees
893
Open
CN¥28.50
High
CN¥28.78
Low
CN¥25.50
Mkt. cap
3.35B
Avg. vol.
5.78M
Volume
7.05M
Dividend
0.17%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jul 16, 2026
52-wk high
CN¥32.58
52-wk low
CN¥18.44
EPS
-CN¥0.63
Shares outstanding
115.28M
No. of employees
893
News stories
From sources across the web
About Hubei Goto Biopharm Group Co Ltd
CEO-
Employees893
FoundedMay 15, 2006
Headquarters-
SectorBiotechnology
Websitegotopharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
163.18M
152.67M
151.11M
161.94M
Cost of goods sold
134.14M
131.32M
162.57M
124.94M
Cost of revenue
134.14M
131.32M
162.57M
124.94M
Research and development expenses
22.03M
15.43M
18.49M
12.31M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16.01M
16.81M
17.63M
11.98M
Operating expense
34.23M
33.24M
32.24M
22.81M
Total operating expenses
168.37M
164.56M
194.81M
147.76M
Operating income
-5.19M
-11.89M
-43.70M
14.18M
Other non operating income
-96.32K
-1.80M
1.53M
-1.30M
EBT including unusual items
-18.77M
-30.50M
-51.56M
-1.28M
EBT excluding unusual items
-18.17M
-23.92M
-57.37M
128.89K
Income tax expense
-4.88M
-7.72M
-7.26M
-2.40M
Effective tax rate
26.01%
25.33%
14.08%
187.86%
Other operating expenses
-4.88M
-3.09M
-3.56M
-3.13M
Net income
-12.23M
-21.28M
-40.92M
3.20M
Net profit margin
-7.50%
-13.94%
-27.08%
1.98%
Earnings per share
-
-
-
-
Interest and investment income
320.18K
370.64K
24.69K
67.99K
Interest expense
-13.14M
-10.68M
-13.61M
-12.82M
Net interest expenses
-12.82M
-10.30M
-13.58M
-12.75M
Depreciation and amortization charges
-
-
-
-
EBITDA
21.22M
-1.14M
-14.86M
43.02M
Gain or loss from assets sale
1.57M
-1.57M
1.44M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer